The European Cystic Fibrosis Society-Clinical Trials Network: an international network to optimize clinical research for a rare disease

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F13%3A10294107" target="_blank" >RIV/00064203:_____/13:10294107 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11130/13:10294107

Výsledek na webu

<a href="http://dx.doi.org/10.4155/cli.13.79" target="_blank" >http://dx.doi.org/10.4155/cli.13.79</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.4155/cli.13.79" target="_blank" >10.4155/cli.13.79</a>

Jazyk výsledku

angličtina

Název v původním jazyce

The European Cystic Fibrosis Society-Clinical Trials Network: an international network to optimize clinical research for a rare disease

Popis výsledku v původním jazyce

The European Cystic Fibrosis Society-Clinical Trials Network was established in 2009 as an initiative of the learned European Cystic Fibrosis Society. Its aim is to optimize the development and evaluation of new and approved treatments for cystic fibrosis through efficient clinical studies in Europe. The European Cystic Fibrosis Society-Clinical Trials Network is composed of 30 selected sites across 11 European countries. Its activities are supported by a coordinating center, steering and executive committees and committees for protocol review, standardization, training, networking and data safety monitoring board. The current projects are to set up an investigator-initiated trial, to implement central laboratories for outcome measures, to move new surrogate end points forward and to facilitate quality within the network through providing a quality-improvement program. A new expansion is planned in the near future.

Název v anglickém jazyce

The European Cystic Fibrosis Society-Clinical Trials Network: an international network to optimize clinical research for a rare disease

Popis výsledku anglicky

The European Cystic Fibrosis Society-Clinical Trials Network was established in 2009 as an initiative of the learned European Cystic Fibrosis Society. Its aim is to optimize the development and evaluation of new and approved treatments for cystic fibrosis through efficient clinical studies in Europe. The European Cystic Fibrosis Society-Clinical Trials Network is composed of 30 selected sites across 11 European countries. Its activities are supported by a coordinating center, steering and executive committees and committees for protocol review, standardization, training, networking and data safety monitoring board. The current projects are to set up an investigator-initiated trial, to implement central laboratories for outcome measures, to move new surrogate end points forward and to facilitate quality within the network through providing a quality-improvement program. A new expansion is planned in the near future.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

EE - Mikrobiologie, virologie

OECD FORD obor

—

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2013

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Clinical Investigation

ISSN

2041-6792

e-ISSN

—

Svazek periodika

3

Číslo periodika v rámci svazku

10

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

6

Strana od-do

921-926

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—